Mohammad Al-Mahdi Al-Karagholi

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 36

Top Topics

Systematic Review

Botulinum Toxin

Signaling Pathway

Top Venues

Cephalalgia : an international journal of headache

Journal of clinical medicine

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammad Al-Mahdi Al-Karagholi, Nanna Arngrim, Messoud Ashina
Migraine headache and aura induced by hypoxia. The Journal of physiology (2024)
Andreas Vinther Thomsen, Mohammad Al-Mahdi Al-Karagholi, Anders Hougaard, Sisse Rye Ostrowski, Ole Birger Pedersen, Thomas Folkmann Hansen, Messoud Ashina
Investigations of the migraine-provoking effect of levcromakalim in patients with migraine with aura. Cephalalgia : an international journal of headache 44 (3) (2024)
Mohammad Al-Mahdi Al-Karagholi, Veberka Kalatharan, Hashmat Ghanizada, Christian Gram, Gregory Dussor, Messoud Ashina
Prolactin in headache and migraine: A systematic review of clinical studies. Cephalalgia : an international journal of headache 43 (2) (2023)
Mi Ji Lee, Mohammad Al-Mahdi Al-Karagholi, Uwe Reuter
New migraine prophylactic drugs: Current evidence and practical suggestions for non-responders to prior therapy. Cephalalgia : an international journal of headache 43 (2) (2023)
Mohammad Al-Mahdi Al-Karagholi, Veberka Kalatharan, Hashmat Ghanizada, Gregory Dussor, Messoud Ashina
Prolactin in headache and migraine: A systematic review of preclinical studies. Headache (2023)
Veberka Kalatharan, Mohammad Al-Mahdi Al-Karagholi
Targeting Peripheral N-Methyl-D-Aspartate Receptor (NMDAR): A Novel Strategy for the Treatment of Migraine. Journal of clinical medicine 12 (6) (2023)
Mohammad Al-Mahdi Al-Karagholi
Targeting CGRP pathways and aura: A peripheral site with a central effect. Cephalalgia : an international journal of headache 43 (12) (2023)
Mohammad Al-Mahdi Al-Karagholi
Involvement of Potassium Channel Signalling in Migraine Pathophysiology. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Mohammad Al-Mahdi Al-Karagholi
Involvement of Potassium Channel Signalling in Migraine Pathophysiology. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Veberka Kalatharan, Mohammad Al-Mahdi Al-Karagholi
Targeting Peripheral N-Methyl-D-Aspartate Receptor (NMDAR): A Novel Strategy for the Treatment of Migraine. Journal of clinical medicine 12 (6) (2023)
Mi Ji Lee, Mohammad Al-Mahdi Al-Karagholi, Uwe Reuter
New migraine prophylactic drugs: Current evidence and practical suggestions for non-responders to prior therapy. Cephalalgia : an international journal of headache 43 (2) (2023)
Mohammad Al-Mahdi Al-Karagholi
Targeting CGRP pathways and aura: A peripheral site with a central effect. Cephalalgia : an international journal of headache 43 (12) (2023)
Mohammad Al-Mahdi Al-Karagholi
Involvement of Potassium Channel Signalling in Migraine Pathophysiology. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Veberka Kalatharan, Mohammad Al-Mahdi Al-Karagholi
Targeting Peripheral N-Methyl-D-Aspartate Receptor (NMDAR): A Novel Strategy for the Treatment of Migraine. Journal of clinical medicine 12 (6) (2023)
Mohammad Al-Mahdi Al-Karagholi, Veberka Kalatharan, Hashmat Ghanizada, Christian Gram, Gregory Dussor, Messoud Ashina
Prolactin in headache and migraine: A systematic review of clinical studies. Cephalalgia : an international journal of headache 43 (2) (2023)
Thien Phu Do, Christina Deligianni, Sarkhan Amirguliyev, Josefin Snellman, Cristina Lopez Lopez, Mohammad Al-Mahdi Al-Karagholi, Song Guo, Messoud Ashina
Second messenger signaling bypasses CGRP receptor blockade to provoke migraine attacks in humans. Brain : a journal of neurology (2023)
Sarkhan Amirguliyev, Pengfei Zhang, Mohammad Al-Mahdi Al-Karagholi, Thien Phu Do
Letter to the Editor regarding "Effect of Altmetric score on manuscript citations: A randomized-controlled trial". Cephalalgia : an international journal of headache 42 (13) (2022)
Mohammad Al-Mahdi Al-Karagholi, Cemile Ceren Hakbilen, Messoud Ashina
The role of high-conductance calcium-activated potassium channel in headache and migraine pathophysiology. Basic & clinical pharmacology & toxicology 131 (5) (2022)
Janu Thuraiaiyah, Lili Kokoti, Mohammad Al-Mahdi Al-Karagholi, Messoud Ashina
Involvement of adenosine signaling pathway in migraine pathophysiology: A systematic review of clinical studies. Cephalalgia : an international journal of headache 42 (8) (2022)
Lili Kokoti, Mohammad Al-Mahdi Al-Karagholi, Fatima Azzahra Elbahi, Hande Coskun, Hashmat Ghanizada, Faisal Mohammad Amin, Messoud Ashina
Effect of K ATP channel blocker glibenclamide on PACAP38-induced headache and hemodynamic. Cephalalgia : an international journal of headache 42 (9) (2022)
Anna Maria Florescu, Anne Louise Tølbøll Sørensen, Henrik Vedel Nielsen, Daniel Tolnai, Lene Dissing Sjö, Katja Lohmann Larsen, Mohammad Al-Mahdi Al-Karagholi
Blastic plasmacytoid dendritic cell neoplasm and cerebral toxoplasmosis: a case report. BMC neurology 22 (1) (2022)
Hashmat Ghanizada, Mohammad Al-Mahdi Al-Karagholi, Christopher S Walker, Nanna Arngrim, Tayla Rees, Jakeb Petersen, Andrew Siow, Mette Mørch-Rasmussen, Sheryl Tan, Simon J O'Carroll, Paul Harris, Lene Theil Skovgaard, Niklas Rye Jørgensen, Margaret Brimble, Jayme S Waite, Brandon J Rea, Levi P Sowers, Andrew F Russo, Debbie L Hay, Messoud Ashina
Amylin Analog Pramlintide Induces Migraine-like Attacks in Patients. Annals of neurology 89 (6) (2021)
Mohammad Al-Mahdi Al-Karagholi, Christian Gram, Cherie Amalie Waldorff Nielsen, Messoud Ashina
Targeting BKCa Channels in Migraine: Rationale and Perspectives. CNS drugs 34 (4) (2021)
Mohammad Al-Mahdi Al-Karagholi, Hashmat Ghanizada, Cherie Amalie Waldorff Nielsen, Anders Hougaard, Messoud Ashina
Opening of ATP sensitive potassium channels causes migraine attacks with aura. Brain : a journal of neurology 144 (8) (2021)
Hashmat Ghanizada, Mohammad Al-Mahdi Al-Karagholi, Nanna Arngrim, Mette Mørch-Rasmussen, Christopher S Walker, Debbie L Hay, Messoud Ashina
Effect of Adrenomedullin on Migraine-Like Attacks in Patients With Migraine: A Randomized Crossover Study. Neurology 96 (20) (2021)
Mohammad Al-Mahdi Al-Karagholi, Jakob Møller Hansen, Dalia Abou-Kassem, Anna Koldbro Hansted, Kumari Ubhayasekera, Jonas Bergquist, László Vécsei, Inger Jansen-Olesen, Messoud Ashina
Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers. Pharmacology research & perspectives 9 (2) (2021)
Nita Katarina Frifelt Wienholtz, Casper Emil Christensen, Ditte Georgina Zhang, Hande Coskun, Hashmat Ghanizada, Mohammad Al-Mahdi Al-Karagholi, Jens Hannibal, Alexander Egeberg, Jacob P Thyssen, Messoud Ashina
Early treatment with sumatriptan prevents PACAP38-induced migraine: A randomised clinical trial. Cephalalgia : an international journal of headache 41 (6) (2021)
Mohammad Al-Mahdi Al-Karagholi, Hashmat Ghanizada, Lili Kokoti, Joachim S Paulsen, Jakob Møller Hansen, Messoud Ashina
Effect of KATP channel blocker glibenclamide on levcromakalim-induced headache. Cephalalgia : an international journal of headache 40 (10) (2020)
Lanfranco Pellesi, Roberto De Icco, Mohammad Al-Mahdi Al-Karagholi, Messoud Ashina
Reducing Episodic Cluster Headaches: Focus on Galcanezumab. Journal of pain research 13 (2020)
Lanfranco Pellesi, Mohammad Al-Mahdi Al-Karagholi, Basit Ali Chaudhry, Cristina Lopez Lopez, Josefin Snellman, Jens Hannibal, Faisal Mohammad Amin, Messoud Ashina
Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers. Cephalalgia : an international journal of headache 40 (11) (2020)
Mohammad Al-Mahdi Al-Karagholi, Hashmat Ghanizada, Cherie Amalie Waldorff Nielsen, Camilla Skandarioon, Josefin Snellman, Cristina Lopez Lopez, Jakob Møller Hansen, Messoud Ashina
Opening of BKCa channels alters cerebral hemodynamic and causes headache in healthy volunteers. Cephalalgia : an international journal of headache 40 (11) (2020)
Mohammad Al-Mahdi Al-Karagholi, Hashmat Ghanizada, Cherie Amalie Waldorff Nielsen, Assan Ansari, Christian Gram, Samaira Younis, Mark B Vestergaard, Henrik Bw Larsson, Lene Theil Skovgaard, Faisal Mohammad Amin, Messoud Ashina
Cerebrovascular effects of glibenclamide investigated using high-resolution magnetic resonance imaging in healthy volunteers. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 41 (6) (2020)
Hashmat Ghanizada, Afrim Iljazi, Håkan Ashina, Thien Phu Do, Mohammad Al-Mahdi Al-Karagholi, Faisal Mohammad Amin, Messoud Ashina
Nocebo response in human models of migraine: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled, two-way crossover trials in migraine without aura and healthy volunteers. Cephalalgia : an international journal of headache 41 (1) (2020)
Mohammad Al-Mahdi Al-Karagholi, Hashmat Ghanizada, Jakob Møller Hansen, Sameera Aghazadeh, Lene Theil Skovgaard, Jes Olesen, Messoud Ashina
Extracranial activation of ATP-sensitive potassium channels induces vasodilation without nociceptive effects. Cephalalgia : an international journal of headache 39 (14) (2019)
Mohammad Al-Mahdi Al-Karagholi, Hashmat Ghanizada, Jakob M Hansen, Lene T Skovgaard, Jes Olesen, Henrik B W Larsson, Faisal M Amin, Messoud Ashina
Levcromakalim, an Adenosine Triphosphate-Sensitive Potassium Channel Opener, Dilates Extracerebral but not Cerebral Arteries. Headache 59 (9) (2019)
Hans-Christoph Diener, Peter J Goadsby, Messoud Ashina, Mohammad Al-Mahdi Al-Karagholi, Alexandra Sinclair, Dimos Mitsikostas, Delphine Magis, Patricia Pozo-Rosich, Pablo Irimia Sieira, Miguel Ja Làinez, Charly Gaul, Nicholas Silver, Jan Hoffmann, Juana Marin, Eric Liebler, Michel D Ferrari
Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial. Cephalalgia : an international journal of headache 39 (12) (2019)